National Academies Recommend Steps to Address Opioid Crisis — Physician’s First Watch

Medical News |
July 14, 2017

National Academies Recommend Steps to Address Opioid Crisis

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The National Academies of Sciences, Engineering, and Medicine have released a set of recommendations intended to address the country's opioid epidemic.

Here are a few of the recommendations:

  • States should provide universal access to evidence-based treatments for opioid use disorder in hospitals, the criminal justice system, and substance-use treatment programs.

  • Preventing opioid-related harms, including overdose deaths, should become a public health priority. For instance, access to naloxone and safe injection equipment should be improved.

  • Prescribers should be free from civil liability and criminal prosecution for prescribing naloxone.

  • The FDA should review the safety and effectiveness of all products containing opioids.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.